MP09: Prostate Cancer: Detection & Screening I

Friday, May 13, 2022

10:30 AM – 11:45 AM

Location: Room 222

Poster Session Moderator(s)

DB

Daniel Barocas, Dr.

Professor of Urology
Vanderbilt University Medical Center
Benjamin Davies, MD

University of Pittsburgh
ZS

Zeyad Schwen, MD

Presentations:

10:30 AM – 11:45 AM

MP09-01: The Role of Prophylactic Antibiotics in Transperineal Prostate Biopsy: A Systematic Review and Metanalysis
Poster Presenter: Emily Cheng
10:30 AM – 11:45 AM

MP09-02: Is it clinically and oncologically safe to omit prostate biopsy in low risk stratified patients?
Poster Presenter: Henning Bahlburg, MD – Marienhospital Herne, Urological Clinic
10:30 AM – 11:45 AM

MP09-03: The efficacy of adjuvant amikacin to oral levofloxacine for prevention of febrile complications following transrectal prostate biopsy
Poster Presenter: Yoshitsugu Nasu, PHD, MD – Okayama Rosai Hospital
10:30 AM – 11:45 AM

MP09-04: A Unique Comparison of Prostate Cancer Detection Rates between Transrectal versus Transperineal MRI-TRUS Fusion Prostate Biopsy among 794 Cases
Poster Presenter: Renee Hogenhout, MSC – Erasmus MC Cancer Institute
10:30 AM – 11:45 AM

MP09-05: Comprehensive analysis of morbidity following transperineal prostate biopsy
Poster Presenter: Vassilios Μ Skouteris, MD – Private Office
10:30 AM – 11:45 AM

MP09-06: Prostate Cancer Detection and Complications of Transperineal versus Transrectal MRI-fusion Guided Prostate Biopsies
Poster Presenter: Dylan Buller, MD – Uconn Health
10:30 AM – 11:45 AM

MP09-07: Safety profile of robotic-assisted transperineal MRI-US-fusion guided biopsy of the prostate
Poster Presenter: Christian Wetterauer – University Hospital Basel
10:30 AM – 11:45 AM

MP09-08: Patient-reported Preference Between Transrectal and Transperineal Prostate Biopsy
Poster Presenter: Sana Noor Siddiqui, DO, MS
10:30 AM – 11:45 AM

MP09-09: The results of transperineal versus transrectal prostate biopsy: an updated systematic review and meta-analysis
Poster Presenter: Jindong Dai
10:30 AM – 11:45 AM

MP09-10: Quantification of Perineural Invasion by Prostate Cancer on Needle Core Biopsy: Implication for Risk Stratification
Poster Presenter: Hiroshi Miyamoto, MD, PhD – University of Rochester Medical Center
10:30 AM – 11:45 AM

MP09-11: The relative impact of spatial parameters on the performance of MRI-US fusion biopsy vs. MRI in-bore biopsy of the prostate
Poster Presenter: Mitchell T. Hayes, MD
10:30 AM – 11:45 AM

MP09-12: Partial prostate gland ablation: lesion location using transperineal mapping biopsy (TPMB)
Poster Presenter: Nelson N. Stone, MD – Nelson N. Stone MDPC
10:30 AM – 11:45 AM

MP09-13: The value of [F-18]Florastamin^R Prostate Specific membranous antigen (PSMA) PET/CT at initial diagnosis of prostate cancer compared with multi-parametric magnetic resonance imaging (mpMRI)
Poster Presenter: Hyeok Jae Kwon, MD – Seoul ST. Mary�S Hospita
10:30 AM – 11:45 AM

MP09-14: Stimulated Raman Histology Allows for Rapid Pathologic Examination of Unprocessed, Fresh Prostate Biopsies
Poster Presenter: Miles Mannas, MD, FRCSC
10:30 AM – 11:45 AM

MP09-15: Investigation of Frozen Section Biopsy Utilization in Magnetic Resonance Imaging–Ultrasonography Fusion-Targeted Prostate Biopsy for High-Risk Prostate Cancer
Poster Presenter: Seung Bin Kim
10:30 AM – 11:45 AM

MP09-16: Quality of Information in Spanish on BRCA and Genetic Testing in Prostate Cancer on YouTube
Poster Presenter: Brett Jacob Friedman, MPH
10:30 AM – 11:45 AM

MP09-17: Predicting incidence versus mortality for cancers associated with overdiagnosis: an overlooked issue for polygenic risk scores and cancer screening
Poster Presenter: Andrew Vickers, PhD – Memorial Sloan Kettering Cancer Center
10:30 AM – 11:45 AM

MP09-18: Longitudinal Outcomes Following Implementation of Baseline PSA Risk Stratification of Men in Their Forties
Poster Presenter: Zoe D. Michael, BS,MS – Duke University
10:30 AM – 11:45 AM

MP09-19: Prostate Cancer Staging with ¹⁸F-PSMA PET/CT after Bone Scintigraphy in men with an Increased Risk of Having Metastatic Disease. a Head-to-Head Comparative Assessment.
10:30 AM – 11:45 AM

MP09-20: Prostate biopsy targeted to Prostate Specific Membrane Antigen (PSMA) foci
Poster Presenter: David Kuppermann, MD